West Pharmaceutical Services Pre-Tax Profit Margin 2010-2024 | WST

Current and historical pre-tax profit margin for West Pharmaceutical Services (WST) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. West Pharmaceutical Services pre-tax profit margin for the three months ending September 30, 2024 was .
West Pharmaceutical Services Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $2.88B $0.59B 20.48%
2024-06-30 $2.88B $0.61B 21.24%
2024-03-31 $2.93B $0.67B 22.78%
2023-12-31 $2.95B $0.70B 23.66%
2023-09-30 $2.93B $0.66B 22.51%
2023-06-30 $2.87B $0.61B 21.21%
2023-03-31 $2.88B $0.65B 22.54%
2022-12-31 $2.89B $0.68B 23.55%
2022-09-30 $2.91B $0.73B 25.20%
2022-06-30 $2.93B $0.78B 26.56%
2022-03-31 $2.88B $0.76B 26.44%
2021-12-31 $2.83B $0.75B 26.44%
2021-09-30 $2.68B $0.68B 25.43%
2021-06-30 $2.52B $0.60B 23.74%
2021-03-31 $2.33B $0.49B 21.07%
2020-12-31 $2.15B $0.40B 18.72%
2020-09-30 $2.04B $0.36B 17.86%
2020-06-30 $1.95B $0.33B 17.01%
2020-03-31 $1.89B $0.31B 16.36%
2019-12-31 $1.84B $0.29B 15.86%
2019-09-30 $1.79B $0.28B 15.68%
2019-06-30 $1.77B $0.28B 15.67%
2019-03-31 $1.75B $0.26B 14.72%
2018-12-31 $1.72B $0.24B 14.03%
2018-09-30 $1.71B $0.23B 13.67%
2018-06-30 $1.68B $0.24B 14.06%
2018-03-31 $1.63B $0.22B 13.33%
2017-12-31 $1.60B $0.22B 13.94%
2017-09-30 $1.57B $0.22B 13.86%
2017-06-30 $1.55B $0.20B 13.14%
2017-03-31 $1.54B $0.22B 14.46%
2016-12-31 $1.51B $0.19B 12.59%
2016-09-30 $1.49B $0.18B 12.10%
2016-06-30 $1.46B $0.12B 8.52%
2016-03-31 $1.43B $0.10B 7.01%
2015-12-31 $1.40B $0.12B 8.28%
2015-09-30 $1.39B $0.12B 8.27%
2015-06-30 $1.40B $0.16B 11.63%
2015-03-31 $1.41B $0.18B 12.54%
2014-12-31 $1.42B $0.17B 11.88%
2014-09-30 $1.42B $0.16B 11.38%
2014-06-30 $1.40B $0.16B 11.13%
2014-03-31 $1.38B $0.15B 10.53%
2013-12-31 $1.37B $0.15B 10.81%
2013-09-30 $1.35B $0.14B 10.53%
2013-06-30 $1.31B $0.13B 9.77%
2013-03-31 $1.29B $0.11B 8.45%
2012-12-31 $1.27B $0.11B 8.52%
2012-09-30 $1.24B $0.10B 8.31%
2012-06-30 $1.23B $0.10B 8.37%
2012-03-31 $1.21B $0.11B 8.82%
2011-12-31 $1.19B $0.09B 7.80%
2011-09-30 $1.17B $0.07B 6.13%
2011-06-30 $1.15B $0.07B 6.17%
2011-03-31 $1.13B $0.07B 6.58%
2010-12-31 $1.11B $0.08B 6.79%
2010-09-30 $1.12B $0.09B 8.12%
2010-06-30 $1.11B $0.09B 8.30%
2010-03-31 $1.09B $0.09B 8.27%
2009-12-31 $1.06B $0.08B 7.87%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36